Identification
Personal identification
- Full name
- Rita Mafalda dos Santos Rocha do Rosário
Citation names
- Rocha, Rita
Author identifiers
- Ciência ID
- 0D18-5B08-2B80
- ORCID iD
- 0000-0003-1193-8320
Email addresses
- rita.rocha@nms.unl.pt (Professional)
Addresses
- NOVA Medical School. Campo dos Mártires da Pátria, 1169-056, Lisboa, Lisboa, Portugal (Professional)
Websites
Knowledge fields
- Medical and Health Sciences - Medical Biotechnology
Education
| Degree | Classification | |
|---|---|---|
|
2011
Concluded
|
Bioquímica (Doutoramento)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
"Structural impact of ambiguous CUG decoding in Candida albicans" (THESIS/DISSERTATION)
|
Aprovada com distinção e louvor - approved |
|
2003
Concluded
|
Bioquímica (Licenciatura)
Universidade do Porto Faculdade de Ciências, Portugal
|
15 (0-20) |
Affiliation
Science
| Category Host institution |
Employer | |
|---|---|---|
| 2022/07/01 - Current | Science and Technology Management | Universidade NOVA de Lisboa NOVA Medical School, Portugal |
| Universidade NOVA de Lisboa NOVA Medical School, Portugal | ||
| 2015/12/01 - 2022/06/30 | Researcher (Research) | Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
| 2020 - 2021 | Science and Technology Management | YourBiome Therapeutics, Portugal |
| 2011 - 2015 | Postdoc (Research) | Universidade do Porto Faculdade de Medicina, Portugal |
Teaching in Higher Education
| Category Host institution |
Employer | |
|---|---|---|
| 2013 - 2020 | Invited Adjunct Teacher (Polytechnic Teacher) | Escola Superior Saúde Santa Maria, Portugal |
Projects
Grant
| Designation | Funders | |
|---|---|---|
| 2015 - 2022 | Structural and functional characterization of K+ transport in bacteria
SFRH/BPD/111525/2015
Post-doc Fellow
|
Concluded
|
| 2011 - 2015 | Unveiling the molecular basis of the echinocandins resistance - the first-line antifungals
Pfizer, Inc (USA) | WS814116.
Post-doc Fellow
|
|
| 2013 - 2013 | ASPIRE - Translational research project for development of a novel protein affinity
tag
IBMC
Principal investigator
|
|
| 2005 - 2010 | Determination of the 3D-structure of the translational factors that mediate a genetic
code change in Candida albicans
SFRH/BD/15233/2004
PhD Student Fellow
|
Contract
| Designation | Funders | |
|---|---|---|
| 2026 - Current | MetaBoost: Metabolic Reprogramming for Neuronal Differentiation
01248627 — MetaBoost
Researcher
|
Horizon Europe Excellent Science
Ongoing
|
| 2025 - Current | NEUROSHIELD - Novel small molecule activator of neuroinflammation in Parkinson’s Disease
101188579 - NEUROSHIELD
Researcher
|
Horizon Europe Excellent Science
Ongoing
|
| 2025 - Current | HUBP2C: Hub de Inovação Pré-clínica-para-Clínica da NOVA Medical School
HUBP2C
Researcher
|
Lisboa 2030
Ongoing
|
| 2024 - Current | NeuroTarget: Biomarker and a therapeutic target for metastatic breast cancer (Stage
1)
NeuroTarget
Researcher
|
Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona 'la Caixa'
Concluded
|
| 2023 - Current | ASSIST: AI Scalable Solution for ST Myocardial Infarction
ASSIST
Project Manager
|
EIT Health
Concluded
|
| 2025 - 2025 | CURE-AF: Clinical Utilization and Evidence Generation for Real-time ECGI in Atrial
Fibrillation
CURE-AF
Project Manager
|
EIT Health
Concluded
|
| 2023 - 2025 | TrainR4U: Training Robot for Ultrassound
TrainR4U
Project Manager
|
EIT Health
Concluded
|
| 2018/07/26 - 2022/07/25 | Characterization of the molecular properties of the K+ homeostasis machinery in a
bacterium
PTDC/BIA-BQM/29863/2017
Principal investigator
Instituto de Biologia Molecular e Celular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
| 2018 - 2022 | Characterization of the molecular properties of the K+ homeostasis machinery in a
bacterium
PTDC/BIA-BQM/29863/2017
Co-Principal Investigator (Co-PI)
|
|
| 2017 - 2021 | Bacterial K+ transporters are potential antimicrobial targets: mechanisms of transport
and regulation
FLAD LIFE SCIENCE 2020
Post-doc
|
Concluded
|
| 2011 - 2015 | Unveiling the molecular basis of echinocandins resistance - the first-line antifungals.
WS814116
Post-doc
Universidade do Porto Faculdade de Medicina, Portugal
|
Pfizer Inc
Concluded
|
| 2011 - 2012 | Clinical efficacy of a novel technology for microbial load decontamination in hospital
intensive care units
ASP - Johnson & Johnson, Inc.|Tracking number: 11-ASP-001
Researcher
|
|
| 2010 - 2011 | In vitro effect of antifungal combinations against Candida species
Pfizer Tracking Number WS718413
Researcher
|
|
| 2010 - 2011 | QUITORAL: development of new prototypes with applications on oral medicine having
chitosan as antimicrobial agent
QREN-ADI Project 3474
Researcher
|
|
| 2005/07/01 - 2008/12/30 | Molecular study of the virulence mechanism of Candida albicans
POCI/SAU-IMI/61598/2004
Researcher
Universidade do Porto Faculdade de Medicina, Portugal
Universidade de Aveiro, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2005/06/01 - 2008/05/31 | Determination of the 3D-structure of the translational factors that mediate a genetic
code change in Candida albicans.
POCI/BIA-PRO/55472/2004
Researcher
Universidade de Aveiro, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
| 2005/02/01 - 2008/04/30 | Understanding morphogenesis and sexual reproduction induced by an alteration to the
genetic code in Candida albicans
POCI/BIA-MIC/55466/2004
Researcher
Universidade de Aveiro, Portugal
Universidade de Aveiro, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
Outputs
Publications
| Conference paper |
|
| Conference poster |
|
| Journal article |
|
| Preprint |
|
Intellectual property
| Patent |
|
Distinctions
Award
| 2007 | Best innovation project in food biotechnology |
| 2007 | Best poster presentation in the international |
